CNTA
Centessa Pharmaceuticals PLC ADR
NASDAQ: CNTA · HEALTHCARE · BIOTECHNOLOGY
$39.45
-0.03% today
Updated 2026-04-29
Market cap
$6.10B
P/E ratio
—
P/S ratio
406.76x
EPS (TTM)
$-1.46
Dividend yield
—
52W range
$11 – $40
Volume
3.0M
Centessa Pharmaceuticals PLC ADR (CNTA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-1,385.00%
ROE
-42.50%
ROA
-20.50%
Debt/equity
0.39x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $0.00 | $-5.28M | — | — | — |
| 2020 | $0.00 | $-10.66M | — | — | — |
| 2021 | — | $-381.90M | — | — | — |
| 2022 | $0.00 | $-216.21M | — | — | — |
| 2023 | $6.85M | $-151.09M | 100.00% | -2,499.39% | -2,204.65% |
| 2024 | $0.00 | $-235.76M | — | — | — |
| 2025 | $15.00M | $-197.53M | 100.00% | -1,384.61% | -1,316.88% |